Phathom Pharmaceuticals to participate in upcoming investor conferences
Phathom Pharmaceuticals said members of its management team are scheduled to participate in upcoming investor conferences.
FLORHAM PARK, N.J., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT, a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participa…